Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited gives notice that, on 4 August 2020 the Company issued 112,111,111 fully paid ordinary shares (Shares) as well as 6,500,000 Listed Options (Options) (exercisable at $0.03 expiring on or before 28th April 2023) as part of the Placement announced to ASX on the 29th July 2020 and as part of lead manager agreement.

Read the notice.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.